chr21-34449342-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM1PM5
The NM_000219.6(KCNE1):c.293G>A(p.Arg98Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000036 in 1,584,134 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R98W) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000219.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
KCNE1 | NM_000219.6 | c.293G>A | p.Arg98Gln | missense_variant | 4/4 | ENST00000399286.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
KCNE1 | ENST00000399286.3 | c.293G>A | p.Arg98Gln | missense_variant | 4/4 | 1 | NM_000219.6 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000425 AC: 6AN: 141054Hom.: 0 Cov.: 17
GnomAD3 exomes AF: 0.0000477 AC: 12AN: 251414Hom.: 0 AF XY: 0.0000441 AC XY: 6AN XY: 135912
GnomAD4 exome AF: 0.0000353 AC: 51AN: 1443080Hom.: 1 Cov.: 28 AF XY: 0.0000320 AC XY: 23AN XY: 718900
GnomAD4 genome AF: 0.0000425 AC: 6AN: 141054Hom.: 0 Cov.: 17 AF XY: 0.0000439 AC XY: 3AN XY: 68320
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2023 | KCNE1: PM2, PS4:Supporting - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jun 18, 2024 | Reported in a patient with presumed LQTS and in a patient with sensorineural hearing loss who also harbored variants in other hearing loss-associated genes (PMID: 27863619, 31941373); In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 24561134, 27863619, 31941373) - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 16, 2017 | The p.Arg98Gln variant in KCNE1 has been previously reported by our laboratory i n two unrelated Caucasian individuals with hearing loss. This variant has been i dentified in 11/246202 of the total chromosomes by the Genome Aggregation Databa se across several populations (gnomAD, http://gnomad.broadinstitute.org; dbSNP r s150454912). Although this variant has been seen in the general population, its frequency is not high enough to rule out a pathogenic role. Computational predic tion tools and conservation analyses suggest that this variant may not impact th e protein, though this information is not predictive enough to rule out pathogen icity. In summary, the clinical significance of the p.Arg98Gln variant is uncert ain. ACMG/AMP Criteria applied: BP4. - |
Long QT syndrome 5;C2676723:Jervell and Lange-Nielsen syndrome 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 22, 2021 | - - |
Cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Advanced Laboratory Medicine, UC San Diego Health, University of California San Diego | Sep 08, 2017 | - - |
Long QT syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 17, 2022 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 98 of the KCNE1 protein (p.Arg98Gln). This variant is present in population databases (rs150454912, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with KCNE1-related conditions. ClinVar contains an entry for this variant (Variation ID: 228764). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on KCNE1 protein function. This variant disrupts the p.Arg98 amino acid residue in KCNE1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 16922724, 17341399, 19907016, 30530868). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 12, 2022 | The p.R98Q variant (also known as c.293G>A), located in coding exon 1 of the KCNE1 gene, results from a G to A substitution at nucleotide position 293. The arginine at codon 98 is replaced by glutamine, an amino acid with highly similar properties. This variant was detected in a control group with baseline QTc interval less than 470ms in a study of drug-induced long QT syndrome (LQTS) (Weeke P et al. J. Am. Coll. Cardiol. 2014;63:1430-7), and was also detected in a proband with hearing loss and no mention of cardiac arrhythmia, who also had variants in other hearing loss-associated genes (Li Y et al. Int. J. Pediatr. Otorhinolaryngol. 2016;91:1-5). This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at